Skip to content
DraconiticResearch
Search Sources API
182,549 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BY-NC-ND 4.0Australian Prescriber

Vanzacaftor, tezacaftor and deutivacaftor fixed-dose combination for cystic fibrosis

Related

  1. CFTR Functional Rescue and Heterogeneous Clinical Outcomes Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis Carrying the W1282R Variant
    Elena Kondratyeva, Anna Efremova, Yuliya Melyanovskaya +9
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  2. Lung function trajectories in children with cystic fibrosis aged 3-17 years: impact of elexacaftor-tezacaftor-ivacaftor on lung function
    B. P. Dyer, M. Deery, R. Heyman +5
    medRxivPreprintCC BY-NC-NDFull textGeneral medicinemedRxiv
  3. Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del -gating and F508del -residual function genotypes: results from an open-label extension study
    James Chmiel, Kimberly Mcbennett, Kimberly Mcbennett +114
    Annals of the American Thoracic SocietyPeer-reviewedCC BY-NCGeneral biologyEpidemiology & public healthHAL
  4. Early nutritional management of cystic fibrosis infants born with meconium ileus
    Laetitia Mouly, Tom Ruffles, Chris Smith
    JPGN reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Constrictive pericarditis in cystic fibrosis: a case report of an emerging cardiovascular complication successfully managed with off-pump pericardiectomy
    European heart journal. Case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
BibTeX
@article{anon2026vanzacaftor,
  title = {{Vanzacaftor, tezacaftor and deutivacaftor fixed-dose combination for cystic fibrosis}},
  journal = {Australian Prescriber},
  year = {2026},
  month = oct,
  doi = {10.18773/austprescr.2026.036},
  url = {https://doi.org/10.18773/austprescr.2026.036},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Vanzacaftor, tezacaftor and deutivacaftor fixed-dose combination for cystic fibrosis
PY  - 2026
DA  - 2026/10/01
JO  - Australian Prescriber
DO  - 10.18773/austprescr.2026.036
UR  - https://doi.org/10.18773/austprescr.2026.036
SN  - 0312-8008
SN  - 1839-3942
ER  -